Although we have previously identified an oncogenic ZEB2/miR-637/HMGA1 signaling axis targeting Vimentin which could promote both migration and invasion in glioma [10], little is known about the role of HMGA1 which is worthy of continuous investigation. Here, VIM is linked to central nervous system cancer.